covid-19 Ventilators patient

No time to waste: repurposing drugs to tackle Covid-19

Reading now: 327
www.pharmaceutical-technology.com

Despite significant funding and research effort, a vaccine against Covid-19 is unlikely to be ready until 2021. Similarly, novel drug development is too slow and impractical a progress to effectively tackle this global pandemic, which, at the time of writing, has killed almost 185,000 people globally A more immediate alternative approach is repurposing existing drugs; a strategy often used in the oncology space.

Borrowing drugs from other indications is a time saver because these drugs will already have proven themselves to be safe in pre-clinical and early clinical testing, meaning they can be fast-tracked straight into the final stage of clinical development, Phase III, to evaluate their safety and efficacy as Covid-19 treatment.

Read more on pharmaceutical-technology.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA